Your browser doesn't support javascript.
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations.
Tiezzi, Camilla; Vecchi, Andrea; Rossi, Marzia; Cavazzini, Davide; Bolchi, Angelo; Laccabue, Diletta; Doselli, Sara; Penna, Amalia; Sacchelli, Luca; Brillo, Federica; Meschi, Tiziana; Ticinesi, Andrea; Nouvenne, Antonio; Donofrio, Gaetano; Zanelli, Paola; Benecchi, Magda; Giuliodori, Silvia; Fisicaro, Paola; Montali, Ilaria; Ceccatelli Berti, Camilla; Reverberi, Valentina; Montali, Anna; Urbani, Simona; Pedrazzi, Giuseppe; Missale, Gabriele; Telenti, Amalio; Corti, Davide; Ottonello, Simone; Ferrari, Carlo; Boni, Carolina.
  • Tiezzi C; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Vecchi A; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Rossi M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Cavazzini D; Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
  • Bolchi A; Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
  • Laccabue D; Interdepartmental Center Biopharmanet-Tec, University of Parma, Parma, Italy.
  • Doselli S; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Penna A; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Sacchelli L; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Brillo F; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Meschi T; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Ticinesi A; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Nouvenne A; Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Donofrio G; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Zanelli P; Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Benecchi M; Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Giuliodori S; Department of Veterinary Science, University of Parma, Parma, Italy.
  • Fisicaro P; Unità di Immunogenetica dei Trapianti, Azienda Ospedaliero Universitaria di Parma, Parma, Italy.
  • Montali I; Unità di Immunogenetica dei Trapianti, Azienda Ospedaliero Universitaria di Parma, Parma, Italy.
  • Ceccatelli Berti C; Unità di Immunogenetica dei Trapianti, Azienda Ospedaliero Universitaria di Parma, Parma, Italy.
  • Reverberi V; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Montali A; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Urbani S; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Pedrazzi G; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Missale G; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Telenti A; UO Immunoematologia e Medicina Trasfusionale, Dipartimento Diagnostico, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Corti D; Department of Neuroscience - Biophysics and Medical Physics Unit, University of Parma, Parma, Italy.
  • Ottonello S; Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Ferrari C; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Boni C; Vir Biotechnology, San Francisco, CA 94158, USA.
iScience ; 26(6): 106940, 2023 Jun 16.
Статья в английский | MEDLINE | ID: covidwho-2326673
ABSTRACT
Humoral immunity is sensitive to evasion by SARS-CoV-2 mutants, but CD8 T cells seem to be more resistant to mutational inactivation. By a systematic analysis of 30 spike variant peptides containing the most relevant VOC and VOI mutations that have accumulated overtime, we show that in vaccinated and convalescent subjects, mutated epitopes can have not only a neutral or inhibitory effect on CD8 T cell recognition but can also enhance or generate de novo CD8 T cell responses. The emergence of these mutated T cell function enhancing epitopes likely reflects an epiphenomenon of SARS-CoV-2 evolution driven by antibody evasion and increased virus transmissibility. In a subset of individuals with weak and narrowly focused CD8 T cell responses selection of these heteroclitic-like epitopes may bear clinical relevance by improving antiviral protection. The functional enhancing effect of these peptides is also worth of consideration for the future development of new generation, more potent COVID-19 vaccines.
ключевые слова

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Тип исследования: Прогностическое исследование / Систематический обзор/метаанализ Темы: Вакцина / Варианты Язык: английский Журнал: IScience Год: 2023 Тип: Статья Аффилированная страна: J.isci.2023.106940

Документы, близкие по теме

MEDLINE

...
LILACS

LIS


Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Тип исследования: Прогностическое исследование / Систематический обзор/метаанализ Темы: Вакцина / Варианты Язык: английский Журнал: IScience Год: 2023 Тип: Статья Аффилированная страна: J.isci.2023.106940